Trial intelligence / Profile preview

Long Term Vitamin D Supplementation on Insulin Sensitivity in Centrally Obese Adults

NCT01052181Phase 4Completed

Start
Jan 2010
Primary completion
Jun 2012
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in insulin resistance (IR) comparing Vitamin D supplementation with Placebo (2 arms). Primary endpoint: Oral Glucose Insulin Sensitivity Index at 1 year. Started Jan 2010; status: completed.

02

Drugs

vitamin d
03

Conditions

insulin resistance (IR)

Beyond the preview

Go deeper on NCT01052181.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01052181.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call